Sometimes We Can Have Nice Things: Our 10 Favorite Feel-Good Stories of 2023
Here’s the best, most inspiring and coolest science we encountered this year
Sometimes We Can Have Nice Things: Our 10 Favorite Feel-Good Stories of 2023
Here’s the best, most inspiring and coolest science we encountered this year
The Biggest Health and Medicine Stories of 2023
From new uses for weight-loss drugs to the first CRISPR gene editing therapy, these were some of the most impactful health stories of the year
FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease
Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed
U.K. Becomes First Country to Approve a CRISPR Disease Treatment
A newly approved CRISPR therapy could transform the treatment of sickle cell disease and beta-thalassemia—but the technology is expensive
Precision Medicine Has Been Overhyped
A new book argues that genomics is overshadowing environmental and social solutions to better health for all
Gene Therapy for Blindness Appears Initially Effective, Says U.S. FDA
The treatment will be reviewed by an outside panel this week
A Possible Cure for "Bubble Boy" Disease Will Cost $665,000--Per Dose
The gene therapy could save kids with severe combined immune deficiency
Chinese Scientists to Pioneer First Human CRISPR Trial
Gene-editing technique to treat lung cancer is due to be tested in people in August
Promising Gene Therapies Pose Million-Dollar Conundrum
Economists, investors and medical insurers can’t figure out how to pay for cutting-edge drugs
Obscure Disease May Offer Backdoor to New Treatments for Alzheimer's and Other Killers
Progressive supranuclear palsy has become a test bed for therapies aimed at the tau protein thought to be behind many devastating neurodegenerative disorders
Taking Gene-Editing to the Next Level
Scientists use a process developed by bacteria to manipulate RNA
3-Person Embryos May Fail to Vanquish Mutant Mitochondria
A technique to stop children from inheriting mitochondrial diseases has the potential to backfire